We Help You Understand
Treatment Decisions.
CancerCareE is not a hospital, not a medical provider. We are an independent platform that helps patients understand treatment options and—only at their explicit request—forwards their information to vetted institutions.
- ✦ $0 patient fees — We never charge patients
- ✦ Independent information on treatment pathways
- ✦ At your request, we introduce you to vetted institutions
- ✦ All medical decisions made by licensed physicians
Request Your Free Introduction
We forward only your name and contact information. No medical data is collected.
No fees. No obligation.
Legal Framework • Financial Transparency
Platform Transparency
Data from our network. Updated regularly.
Patients, Families & Physicians
We provide information and connection pathways to support informed decisions.
For Patients & Families
- Independent information on treatment options
- Connection to vetted institutions at your request
- Transparent cost information
- Multi-language support
For Advanced Cancer Cases
- Options when standard treatments are exhausted
- Introduction to centers offering CAR-T, TIL, NK, Gamma Delta
- Clinical trial matching information
For Referring Physicians
- Secure physician-to-physician portal
- Peer case review by specialist oncologists
- Clinical trial matching
- Anonymized outcome data
The Access Intelligence Framework
A rigorous, evidence-based approach to evaluating treatment pathways across three critical dimensions.
Clinical Viability
We analyze publicly available clinical data, peer-reviewed literature, and treatment guidelines to assess the scientific foundation of each pathway.
- Evidence-based therapy evaluation
- Clinical trial registry analysis
- Physician credential verification
Logistical Feasibility
We map the practical realities of cross-border care, from institutional accreditation to patient support infrastructure.
- International accreditation status (JCI, ISO)
- Language and cultural support
- Geographic accessibility analysis
Financial Transparency
We maintain absolute clarity on costs, fees, and our own revenue model—no hidden charges, no surprises.
- $0 patient facilitation fees
- Clear referral fee disclosure
- Direct hospital billing transparency
Global Oncology Access Trends
Data-driven insights from our introduction platform, reflecting real patient inquiry patterns.
Advanced Cellular & Immunotherapy
Evidence-based information on cutting-edge treatment options.
CAR-T Cell Therapy
Genetically modified T-cells targeting specific cancer antigens.
Lymphoma • Leukemia • Myeloma Learn about CAR-T →Gamma Delta T-Cell
Innate immune cells effective against solid tumors without HLA matching.
Solid Tumors • Lung • Liver Learn about Gamma Delta →TIL Therapy
Tumor-Infiltrating Lymphocytes expanded from the patient's own tumor.
Melanoma • Cervical • Ovarian Learn about TIL →NK Cell Therapy
Natural Killer cells providing innate immunity against cancer cells.
Blood Cancers • Solid Tumors Learn about NK cells →Is Advanced Cellular Therapy an Option?
An honest assessment framework based on clinical evidence.
✓ May Be Appropriate If
- Relapsed after 2+ standard treatments
- Specific cancer type (B-ALL, DLBCL, Myeloma)
- Adequate organ function
- Performance status ECOG 0-2
✕ May Not Be Suitable If
- Early-stage cancer
- Severe organ dysfunction
- Active autoimmune disease
- Performance status ECOG 3-4
? Requires Expert Review If
- Solid tumors (trial-dependent)
- Elderly patients (case-by-case)
- Prior CAR-T failure
- Rare cancer types
This is an informational guide, not medical advice.
Treatment Comparisons
Evidence-based comparisons to help you understand your options.
CAR-T vs Chemotherapy
Compare efficacy, side effects, and costs.
Read comparison →NK Cells vs CAR-T
Natural killer cells or modified T-cells.
Read comparison →China vs USA in Cellular Therapy
Cost, wait times, clinical trials, and quality of care.
Read comparison →TIL vs Immunotherapy
TIL compared with immune checkpoint inhibitors.
Read comparison →Research & Institutional Gateway
Collaborate with us to expand ethical, transparent patient access pathways.
For Hospitals & Clinics
Provide your clinical trial data and treatment pathways to our global patient network through our secure, compliance-first platform.
Learn More →For Universities & Researchers
Collaborate on cross-border oncology access research. Access our anonymized market intelligence and patient inquiry data.
Explore Collaboration →For Pharma & Biotech
Integrate your patient access programs with our intelligence platform. Reach qualified patients through ethical, transparent channels.
Partner With Us →Frequently Asked Questions
Common questions about our platform.